1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ALNYLAM PHARMACEUTICALS INC
Alnylam Pharmaceuticals Inc
XNAS: ALNY

Alnylam Pharma Inc Live Stock Price Today, Share Analysis and Chart

Falling Comet
about

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam's commercial RNAi thera...

Read More
309.49 8.30 (2.76%)
37.55% Fall from 52W High
2.2M
XNAS Volume

XNAS 30 Apr, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Alnylam Pharma Inc is on 08 May 2026 for the purpose of Alnylam Pharmaceuticals Inc Annual General Meeting for 2026 See details
Durability score
High Financial Strength
55.6 / 100
Valuation Score
Expensive Valuation
28.8 / 100
Momentum Score
Technically Bearish
23.4 / 100
Falling Comet These stocks have good quality. But weak financials and technicals should make investors cautious View Similar Embed DVM
Analyst Price Target
449
1Yr Price target upside is 45%
25 analysts

10

S

8

W

0

O

3

T

SWOT Analysis

Alnylam Pharma Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..